Sean Schantzen

See the following -

Crowdfunding The Next Medical Cure

Mohana Ravindranath | The Washington Post | July 8, 2013

Creating a new medical device is not an inexpensive exercise. There are development costs, clinical trial expenses, and the lengthy process of getting a piece of new equipment approved by the Food and Drug Administration. Read More »

Reinventing Investment: The Funding Landscape Of Life Science Shifts For Good

Nicole Fisher | Forbes.com | March 31, 2014

The legal landscape and requirements for a life sciences company to fundraise in the US are a nightmare, to put it gently. Guidelines changed recently with the Jumpstart Our Business Startups (JOBS) Act, and the sheer number of investment strategies for a life science startup executive to understand and pursue are staggering.

Read More »